Digoxin/flecainideLack of efficacy following in-utero exposure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1953卷 / 1期

关键词：

D O I：

10.1007/s40278-023-37602-6

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：167 / 167

相关论文

共 50 条

[11] ColecalciferolHypercalcaemia following in-utero exposure: case report
Reactions Weekly, 2017, 1667 (1) : 92 - 92
[12] MetyraponeHyponatraemia following in-utero exposure: case report
Reactions Weekly, 2020, 1811 (1) : 186 - 186
[13] PropranololHypoglycaemia following in-utero exposure: case report
Reactions Weekly, 2016, 1611 (1) : 146 - 146
[14] AdalimumabExencephaly following in-utero exposure: case report
Reactions Weekly, 2021, 1843 (1) : 17 - 17
[15] PramipexoleHydronephrosis following in-utero exposure: case report
Reactions Weekly, 2023, 1970 (1) : 241 - 241
[16] ThiamazoleHypothyroidism following in-utero exposure: case report
Reactions Weekly, 2019, 1748 (1) : 506 - 506
[17] WarfarinEmbryopathy following in-utero exposure: case report
Reactions Weekly, 2018, 1725 (1) : 293 - 293
[18] FingolimodDextrocardia following in-utero exposure: case report
Reactions Weekly, 2018, 1695 (1) : 180 - 180
[19] MetforminPrematurity following in-utero exposure: case report
Reactions Weekly, 2023, 1957 (1) : 359 - 359
[20] Antibacterials/folinic acid/pyrimethamineLack of efficacy following in-utero exposure: case report
Reactions Weekly, 2022, 1936 (1) : 45 - 45

← 1 2 3 4 5 →